Ventyx Biosciences, Inc (VTYX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Ventyx Biosciences (VTYX) klinik sinovlar bosqichlaridan o'tgan holda, og'iz orqali qabul qilinadigan yallig'lanishga qarshi segmentda yetakchi pozitsiyani egallashni maqsad qilgan. GURU.Markets grafigidagi chiziqli narx harakati kompaniyaning joriy holatini tasdiqlaydi, bunda ko'rsatkich 0.05 darajasida turibdi. Biznes avtoimmun patologiyalarni davolash uchun inyeksiyalarga qulay tabletka asosidagi muqobil variantlarni ishlab chiqmoqda, shu bilan birga tibbiy testlar tahlilini tezlashtirish uchun avtomatlashtirilgan dasturiy ta'minot va robototexnikani joriy etmoqda.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_VTYX_-_Ventyx-Biosciences_-_Long-Term-Debt-to-Capital "VTYX: Ventyx Biosciences, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 14.03.2026 | 👁️GURU.Markets👁️")
Ventyx Biosciences (VTYX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Ventyx Biosciences|VTYX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ventyxbio.com|VTYX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Ventyx Biosciences, Inc.|VTYX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Ventyx Biosciences|Tezkor likvidlik ko‘rsatkichi ventyxbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Ventyx Biosciences Inc. - VTYX
Tashqi zarbalarga moliyaviy chidamlilik tartibga soluvchi o'zgarishlar va xomashyo ta'minoti zanjirining zaifliklari fonida Ventyx Biosciences (VTYX) uchun juda muhimdir. Uzoq muddatli qarzlarning kapitalga nisbatini tahlil qilish orqali investor kapital tuzilmasidagi muddati bir yildan ortiq bo'lgan kreditlar ulushini baholaydi, bu esa kompaniyaning leveraj darajasini va defolt xavfisiz qarzlarni to'lash qobiliyatini belgilaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PVLA: Uzoq muddatli qarzning o'z kapitaliga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati rigel.com (RIGL)|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXS (Astria Therapeutics Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|Uzoq muddatli kreditlarning kapitalga nisbati RAPT|Aerovate Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|aclaristx.com (ACRS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KYTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|TLSA (Tiziana Life Sciences Ltd.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CABA (Cabaletta Bio, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ELDN|Uzoq muddatli qarzning kapitalga nisbati AGEN|Uzoq muddatli qarzdorlikning kapitalga nisbati Climb Bio Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Zura Bio Limited ZURA|aTyr Pharmaceuticals (ATYR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ImageneBio Inc IMA|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Immunic Inc (IMUX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATRA|IFRX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|INmune Bio Corporation (INMB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati kezarlifesciences.com (KZR)|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Akari Therapeutics PLC (AKTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ENLV (Enlivex Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati QTTB (q32bio.com)|GeoVax Labs, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati EDSA (edesabiotech.com)|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Carisma Therapeutics|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Aptevo - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati AIM|ADTX (aditxt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga nisbati XORTX Corp XRTX|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzdorlikning kapitalga nisbati iTeos Therapeutics Inc (ITOS)|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati